Skip to content

Evaluate the security and effectiveness of Blood Glucose Test Strip

Evaluate the security and effectiveness of Blood Glucose Test Strip

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049777
Enrollment
Unknown
Registered
2021-08-09
Start date
2021-08-09
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male or female subjects aged 18 and 80 years; 2. Subjects who voluntarily participates the study and willing to comply with the study procedures and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients having any sever comorbidity within 6 months like stroke,acute myocardial infarction, leukemia, aplastic anemia,autoimmune disease and any other serious illness; 2. Subjects who have steroids medication, for example: Flixotide, Seretide 250, Serevent, Advair; 3. Notifiable bloodborne infectious diseases, for example:HIV,Treponema pallidum, HBV.

Design outcomes

Primary

MeasureTime frame
blood glucose;

Countries

China

Contacts

Public ContactWang Yufei

Shanghai Sixth People's Hospital

13386259806@126.com+86 13386259806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026